Detailed Information on Publication Record
2022
Characterization of Clinical-Grade Stem Cells: Microscopic, Cellular, Molecular, and Functional Characterization of Stem Cells and Their Products According to Regulatory Requirements for FDA Approval
SOURALOVÁ, Tereza, Daniela ŘEHÁKOVÁ, Lenka TESAŘOVÁ, Aleš HAMPL, Irena KOUTNÁ et. al.Basic information
Original name
Characterization of Clinical-Grade Stem Cells: Microscopic, Cellular, Molecular, and Functional Characterization of Stem Cells and Their Products According to Regulatory Requirements for FDA Approval
Authors
SOURALOVÁ, Tereza (203 Czech Republic, belonging to the institution), Daniela ŘEHÁKOVÁ (203 Czech Republic, belonging to the institution), Lenka TESAŘOVÁ (203 Czech Republic, belonging to the institution), Aleš HAMPL (203 Czech Republic, belonging to the institution) and Irena KOUTNÁ (203 Czech Republic, guarantor, belonging to the institution)
Edition
1. vyd. Singapore, Stem Cell Production, p. 185-203, 19 pp. Biomedicine & Life Sciences, 2022
Publisher
Springer, Singapore
Other information
Language
English
Type of outcome
Kapitola resp. kapitoly v odborné knize
Field of Study
10601 Cell biology
Country of publisher
Singapore
Confidentiality degree
není předmětem státního či obchodního tajemství
Publication form
printed version "print"
References:
RIV identification code
RIV/00216224:14110/22:00129662
Organization unit
Faculty of Medicine
ISBN
978-981-16-7588-1
Keywords in English
Stem cell production; Stem cell sterility; Stem cell clinical trials; Stem cell bioreactor; cGMP inspection
Tags
Tags
International impact, Reviewed
Změněno: 23/2/2024 09:18, Mgr. Marie Šípková, DiS.
Abstract
V originále
Stem cells have unique properties that make them an exceptional source for regenerative medicine. Various types of stem cells and their products are used for therapeutic purposes, and they differ in their morphology, molecular markers, and functional characteristics. Nevertheless, to comply with regulatory requirements, strict criteria must be fulfilled. Here, we provide a comprehensive overview of the characterization criteria for human mesenchymal stem cells (hMSCs), human neural stem cells (hNSCs), human pluripotent stem cells (hPSCs), and human hematopoietic stem cells (hHSCs) that constitute the starting material for cell therapy products.
Links
CZ.02.1.01/0.0/0.0/16_013/0001826, interní kód MU (CEP code: EF16_013/0001826) |
| ||
NV18-08-00412, research and development project |
|